Texas 2023 - 88th Regular

Texas House Bill HB2891 Latest Draft

Bill / Engrossed Version Filed 04/26/2023

Download
.pdf .doc .html
                            88R15366 AMF-F
 By: Talarico, Garcia, Oliverson, Bucy, H.B. No. 2891
 Allison


 A BILL TO BE ENTITLED
 AN ACT
 relating to the use of glucagon medication on certain public and
 private school campuses.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 168.001, Health and Safety Code, is
 amended by adding Subdivision (1-a) and amending Subdivisions (4)
 and (5) to read as follows:
 (1-a)  "Glucagon medication" means any medication used
 to treat hypoglycemia that contains glucagon.
 (4)  "School," unless the context clearly indicates
 otherwise, means a school district [public elementary or secondary
 school. The term does not include an open-enrollment charter
 school established under Subchapter D, Chapter 12, Education Code].
 (5)  "School employee," unless the context clearly
 indicates otherwise, means a person employed by:
 (A)  a school;
 (B)  a local health department that assists a
 school under this chapter; or
 (C)  another entity with which a school has
 contracted to perform its duties under this chapter.
 SECTION 2.  Chapter 168, Health and Safety Code, is amended
 by adding Sections 168.012 and 168.013 to read as follows:
 Sec. 168.012.  MAINTENANCE AND ADMINISTRATION OF GLUCAGON
 MEDICATION. (a) A school district, open-enrollment charter
 school, or private school may adopt and implement a policy
 regarding the maintenance, administration, and disposal of
 glucagon medication at each campus in the district or school.
 (b)  A policy adopted under Subsection (a):
 (1)  must provide that a school nurse or an unlicensed
 diabetes care assistant may:
 (A)  administer glucagon medication to a student
 who is reasonably believed to be experiencing hypoglycemia and for
 whom:
 (i)  a diabetes management and treatment
 plan has been submitted to the district or school; and
 (ii)  an individualized health plan, as
 described by Section 168.003, has been developed for the student;
 and
 (B)  carry glucagon medication prescribed in the
 name of the district or school on the nurse's or assistant's person
 to administer to a student described by Paragraph (A); and
 (2)  may not require a district or school to purchase
 glucagon medication or require the district or school to make any
 other expenditure related to the maintenance or administration of
 glucagon medication that would result in a negative fiscal impact
 on the district or school.
 (c)  The supply of glucagon medication at a campus subject to
 a policy adopted under Subsection (a) must be stored in a secure
 location and be easily accessible to a school nurse and unlicensed
 diabetes care assistant.
 (d)  Notwithstanding any other provision of this chapter, if
 an open-enrollment charter school or private school adopts a policy
 under Subsection (a):
 (1)  the parent or guardian of a student with diabetes
 who is enrolled in the school may submit a diabetes management and
 treatment plan developed in accordance with Section 168.002 to the
 school;
 (2)  the school may seek school employees who are not
 health care professionals to serve as unlicensed diabetes care
 assistants for purposes of administering glucagon medication under
 the policy; and
 (3)  the following provisions of this chapter apply to
 the school as if the school were a school district and to a school
 employee of the school, including a school nurse or unlicensed
 diabetes care assistant, as if the school employee were employed by
 a school district:
 (A)  Section 168.002(c);
 (B)  Section 168.003 with respect to each student
 who submits a diabetes management and treatment plan to the school;
 (C)  Sections 168.004(b) and (c);
 (D)  Section 168.005; and
 (E)  Section 168.009.
 (e)  The executive commissioner, in consultation with the
 commissioner of the Texas Education Agency, shall adopt rules
 regarding the maintenance, administration, and disposal of
 glucagon medication at a school campus in accordance with a policy
 adopted under Subsection (a).
 Sec. 168.013.  PRESCRIPTION OF GLUCAGON MEDICATION. (a) A
 physician or person who has been delegated prescriptive authority
 under Chapter 157, Occupations Code, may prescribe glucagon
 medication in the name of a school district, open-enrollment
 charter school, or private school that adopts a policy under
 Section 168.012(a).
 (b)  A physician or other person who prescribes glucagon
 medication under Subsection (a) shall provide the school district,
 open-enrollment charter school, or private school with a standing
 order for the administration of glucagon medication to a student
 described by Section 168.012(b)(1)(A).
 (c)  The standing order under Subsection (b) is not required
 to be patient-specific, and the glucagon medication may be
 administered to a person without a previously established
 physician-patient relationship.
 (d)  Notwithstanding any other provisions of law,
 supervision or delegation by a physician is considered adequate if
 the physician:
 (1)  periodically reviews the order; and
 (2)  is available through direct telecommunication as
 needed for consultation, assistance, and direction.
 (e)  A pharmacist may dispense glucagon medication to a
 school district, open-enrollment charter school, or private school
 that adopts a policy under Section 168.012(a) without requiring the
 name or any other identifying information relating to the user.
 SECTION 3.  This Act applies beginning with the 2023-2024
 school year.
 SECTION 4.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2023.